Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Piezo Channels in Aging Asthmatic Human Airway Smooth Muscle
Borkar, Niyati A. , Pfeffer-Kleemann, Daniel , Thompson, Martin W., Pabelick, C.M., Hamrick, Samantha K. , Ngassie, Maunick Lefin Koloko , Thompson, M., Prakash, Y. S.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A3075-A3075

10.1164/ajrccm.2025.211.abstracts.a3075 Get It

Abstract Rationale: Asthma in the elderly (AIE) presents a unique challenge characterized by hyperreactive and thickened, fibrotic airways (remodeling) that is not adequately addressed by current therapies. Thus, understanding mechanisms that drive AIE become important. Here, airway smooth muscle (ASM) cells play important roles in normal airway physiology and asthma pathophysiology. Recent discoveries have highlighted the significance of mechanosensitive Piezo (Pz) in health and disease. The lung generates mechanical forces of normal breathing and other maneuvers that are transmitted to bronchial airways via tethering parenchyma. While Pz channels are highly expressed in the lung, their specific role in ASM function remains largely unexplored. In this study, we used human ASM cells to test the hypothesis that increased airway stiffness associated with normal aging blunts Pz expression and mechanosensitive functionality, whereas asthmatic triggers (e.g. inflammation) enhance Pz expression and downstream signaling. Methods: Primary human ASM cells isolated from lungs of young (<45y) vs. aged (>65y) non-asthmatic vs. asthmatic individuals were obtained post-surgery (Mayo Clinic IRB approved). Cells were exposed to mechanical stretch (mimicking breathing) and mediators relevant to asthma (TNFα, IL-13) or fibrosis (TGFβ) to determine expression of Pz1/2 across the age spectrum. Separately, intracellular Ca2+ and contractility responses, proliferation and extracellular matrix (ECM) deposition across age/asthma groups were assessed in response to mechanical stretch and Pz1/2 modulation (inhibitors/activators, genetic approaches). Manipulation of Pz1/2 expression or function in ASM accompanied by mechanical stretch was used to assess impact on canonical Wnt/β-catenin signaling. Results: We observed increased Pz1/2 expression with age and asthma as well as with inflammation and mitogenic stimuli. Functionally, Pz1 agonist, Yoda1 induced increase in intracellular Ca2+, ASM proliferation and ECM deposition with greater effects observed in aging asthmatic ASM. Towards linking mechanosensation (via Pz) to remodeling via Wnt signaling, we find that Wnt3a is upregulated by Yoda1 but suppressed by Pz1 shRNA. Yoda1 stimulates TGFβ-induced Wnt3a and β-catenin, an effect further enhanced under mechanical stretch. Conclusions: By elucidating the role of Pz channels in ASM, we aimed to identify novel therapeutic targets for airway diseases. Understanding how mechanical forces and inflammatory stimuli influence Pz-mediated signaling pathways will lead to the development of innovative strategies to prevent or reverse airway remodeling in elderly asthmatic patients. Acknowledgement: Supported by 24POST1241979 (NAB) and NIH grants R01-HL142061 (CMP and YSP), R01- HL088029 (YSP).
Effects of Stretch on Fetal Airway Store Operated Calcium Entry
Pfeffer-Kleemann, D., Thompson, Martin W., Prakash, Y.S., Pabelick, C.M., Pfeffer-Kleemann, D, Drake, Li Y. , Thompson, M., Pabelick, C.M.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A3074-A3074

10.1164/ajrccm.2025.211.abstracts.a3074 Get It

Abstract Rationale: In premature infants, continuous positive airway pressure (CPAP) serves as an effective respiratory support strategy in the NICU. However, the static stretch induced by CPAP may negatively impact bronchial airway development, leading to hyperreactivity and remodeling, key proponents of asthma. Here, epithelial and airway smooth muscle cells are affected by stretch, but the mechanisms by which effects occur are not well-known. In airway smooth muscle contractility, stromal interaction molecule 1 (STIM1) at the endoplasmic reticulum and plasma membrane Orai1 channels are important mediators of the store operated calcium entry (SOCE) microdomain signaling pathway, facilitating movement of calcium into the cell and triggering downstream remodeling effects. Recently discovered mechanosensitive Piezo (PZ) channels play a critical role in calcium influx upon mechanical stimulation. In this study, we investigated the hypothesis that interplay between mechanosensitive channels such as PZ and the SOCE microdomain promotes calcium in human fetal airway smooth muscle cells (fASM) towards increasing contractility by stretch. Methods: fASM were obtained from 18-22 week abortus following fetal demise (exempt per Mayo IRB). Cells were pretreated with either PZ1 inhibitor GsMTx4 [1uM] or PZ2 inhibitor D-GsMTx4 [1uM] 45 minutes before stretch. Cells were exposed to normal breathing stretch conditions on a FlexCell System at a 5% cyclic strain (40 cycles/minute) and CPAP with static stretch superimposed for 24 hours. Protein expression of PZ channels and key SOCE proteins were quantified. SOCE responses of stretched and control cells were determined using established protocols in fura-2 loaded cells using fluorescence microscopy. Results: Mechanical stretching of fASM increased protein expression of PZ1, STIM1, and Orai1 in a dose dependent manner. Stretch increased intracellular SOCE responses compared to non-stretched controls. PZ1 antagonist GsMTx4 and PZ2 antagonist D-GsMTx4 inhibited stretch-induced Piezo1, STIM1, and Orai1 upregulation. GsMTx4 and D-GsMTx4 blunted stretch and non-stretched induced calcium SOCE responses relative to unstretched control. Conclusions: Our findings suggest that in the context of mechanical stretch, Piezo channels and the downstream SOCE signaling pathway increase in expression and functionality in the fetal airway which may contribute to CPAP associated changes in airway contractility.
Nebulized Platelet-derived Extracellular Vesicles Attenuate Cigarette Smoke-induced Murine Emphysema Via Immunoregulation
Wang, Supeng, Stalboerger, Paul G., Paradise, Christopher J. , MaCranor, B., Daher, A., Du, D., Behfar, Atta , Paradise, C., Vassallo, R.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A3050-A3050

10.1164/ajrccm.2025.211.abstracts.a3050 Get It

Abstract Rationale: We previously reported (PMID: 38325750) that a nebulized exosome product isolated from human platelets (PEP) attenuated murine cigarette smoke (CS)-induced emphysema. To further elucidate the mechanism by which PEP attenuates CS-induced effects in the murine lung, emphysema was induced, and mice were treated with PEP or placebo (saline). Immune and cellular mechanisms affected by PEP were then evaluated in this system. Methods: C57BL6 female black mice were exposed to CS 5 days a week for 3 months and then randomized into PEP-treated or placebo groups. CS-exposed mice were treated with 3 mL of 7.5 mg/mL PEP (∼1 x 1010 extracellular vesicles per mL) or 0.9% saline by nebulization 3 times a week for an additional 4 weeks, using a nose-sealed, pressure and humidity-controlled inhalation tower for 30 minutes. Lung compliance, cutaneous O2 saturation, mean linear intercepts, and lung inflammation were measured during and after the study. Lung tissue was further analyzed by immunostaining, and gene expression analyses to elucidate the molecular mechanisms of PEP's action. Inflammatory and immune regulatory cell markers evaluated included CD4 (CD4+ T lymphocytes), CD4/Foxp3 (T regulatory – Treg) cells, S100A9 (interstitial lung macrophages), and myeloperoxidase (MPO) for neutrophils. Results: Histologic review of lung tissue sections by mean linear intercept counts confirmed prior findings and showed a significant reduction in the free distance of chronic CS exposure-induced alveolar space enlargement in PEP-treated mice (P=0.003). In addition, lung inflammation scores showed a significant overall reduction of the lymphocytic infiltrates in PEP-nebulized lungs compared to the CS-exposed placebo control group (P<0.0001). Further analysis of the immune cell infiltrates revealed increased FOXP3+CD4+ T regulatory cells within the lymphocytic infiltrates (P<0.0001) and decreased S100A9+ interstitial lung macrophages (p=0.0002) and MPO+ neutrophils (p=0.005) in PEP nebulized lungs compared to the placebo controls. PEP-treated mice had similar oxygen saturation levels when compared to the CS control group (94.7±1.47 vs. 95.4±.1.6 respectively). Conclusions: In addition to validating prior findings on the effect of nebulized PEP in mitigating CS-induced murine lung injury and emphysema, the current data suggests an immunoregulatory role for PEP by decreasing inflammatory macrophage and neutrophil infiltration while augmenting anti-inflammatory Treg cell numbers in the lung.
Safety of Liberal Fluid Resuscitation in Patients With Sepsis: A Retrospective Analysis
Seckin, Z.I., Myers, M.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2956-A2956

10.1164/ajrccm.2025.211.abstracts.a2956 Get It

Abstract Background: Intravenous fluid resuscitation is fundamental for sepsis-induced hypoperfusion. The 2021 Surviving Sepsis Campaign recommends 30 mL/kg of intravenous crystalloid within the first three hours. Fluid management in patients with sepsis is challenging due to risk for volume overload hence edema in the lungs and other organs. Conflicting literature debates over whether liberal or restricted fluid administration is optimal in this population. We hypothesized that, despite X-ray findings suggesting volume overload, liberal fluid resuscitation in patients with severe sepsis or septic shock does not increase in-hospital mortality or ventilation requirements. Methods: The study is approved by the Mayo Clinic IRB. We retrospectively studied adult patients admitted to the medical ICU with severe sepsis or septic shock from 2014-2018. Data collected included admission weight, chest Xray (CXR) fluid status (“wet” vs. “dry”), fluid resuscitation volumes at 3 and 24 hours (liberal [≥30 mL/kg] vs. restricted), in-hospital mortality, ventilation need, ICU/hospital length of stay (LOS), admission lactate, baseline NT-proBNP, home oxygen use, and history of heart failure or chronic pulmonary disease. For accuracy, an independent pulmonologist reviewed CXRs, and patients with radiologist-pulmonologist discrepancies were excluded. Results: Of 346 patients, 68% had “wet” CXRs. Patients with “dry” CXRs received greater median fluid resuscitation at both 3 hours (3913 mL vs. 3126 mL, p=0.001) and 24 hours (6085 mL vs. 5435 mL, p=0.0005). Liberal fluid resuscitation was more frequent in patients with “dry” CXR than those with “wet” CXR (72% vs. 57%, p=0.006). In-hospital mortality was lower among patients receiving liberal resuscitation compared to restricted (13% vs. 21%; OR 0.573, 95% CI 0.32-1.02, p=0.04), although in patients with “wet” CXRs, liberal resuscitation did not significantly impact mortality (p=0.17). Need for invasive or noninvasive ventilation tended to be higher in the restricted group compared to the liberal group, though this was not statistically significant (45% vs. 29%; OR 0.48, 95% CI 0.21-1.12, p=0.07). There was no significant difference in ICU or hospital LOS between patients receiving liberal and restricted resuscitation (p=0.14 and p=0.9, respectively). In multivariate analysis, in-hospital mortality was significantly associated with chronic pulmonary disease (p=0.04) and admission lactate (p=0.007) but not with CXR findings (p=0.72) or fluid resuscitation volume (p=0.38). Additionally, neither CXR findings (p=1) nor liberal fluid resuscitation (p=0.07) significantly increased the need for ventilation. Conclusion: Liberal fluid resuscitation in patients with severe sepsis or septic shock appears safe and does not increase mortality or ventilation needs, even in those with radiographic volume overload.
Lower Lobe Mucus Plug Distribution is Associated With Increased Risk for Future Acute Exacerbations Among Tobacco-exposed Persons
Mettler, S.K., Campo, M. Iturrioz, Yen, A., Sonavane, S., Wang, Wei , Cho, M.H. , Mettler, Sofia K. , Wan, Emily S. , Borgaonkar, Ruchita , Nardelli, Pietro , Grumley, Scott , Estépar, R. San José , Díaz, Alejandro A.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2944-A2944

10.1164/ajrccm.2025.211.abstracts.a2944 Get It

Abstract Introduction / Rationale Mucus plugs (MPs) on chest computed tomography (CT) are associated with increased respiratory symptoms, worse lung function, and elevated mortality and acute exacerbations among individuals with GOLD2-4 COPD. Whether mucus plug distribution in the upper versus lower lobes differentially impacts future acute exacerbations (AEs) has been incompletely explored. Methods Data from current and former tobacco users, ages 40-80, with ≥10 pack-years, at the enrollment visit in COPDGene were analyzed. MPs were visually-assessed on chest CTs using a sequential reading system; the MP score was calculated as the number of bronchopulmonary segments with plugs (range 0-18). Among subjects with MPs, the percent of lower lobe MPs (%LLMPs) was calculated as the number of bronchopulmonary segments in the right and left lower lobes divided by the total number of bronchopulmonary segments (range 0-100%). Moderate-to-severe AEs were assessed prospectively biannually for up to 15.5 years. Zero-inflated Poisson regression, adjusting for age, sex, BMI, race, smoking status, pack-years, FEV1% predicted, history of AEs (year prior to enrollment), and clinical center assessed the relationship between %LLMPs, total MPs, and prospective AEs; duration of follow-up was included as the offset. Subgroup analyses by lung function category (GOLD0, GOLD 1-4 COPD, and Preserved Ratio Impaired Spirometry, PRISm) were also performed using the same model. Results Among 10,198 tobacco-exposed individuals, 9,406 subjects (mean age 59.7±9.0, 53.4% male, 68% non-Hispanic white) had chest CT scans scored for MPs. The overall prevalence of MP>0 was 30.4%, with an average MP score of 0.78±1.88 and average %LLMP of 48%±39%. The prevalence of MPs varied by lung function category (20.1% GOLD0, 26.2% PRISm, 40.8% COPD) as did the mean MP score (0.28±0.93 GOLD0, 0.49±1.38 PRISm, 1.30±2.42 COPD) (Figure 1). The %LLMP also varied by lung function category (33%±39% GOLD0, 38%±37% PRISm, 57%±37% COPD). Among subjects with MPs>0 (n=2,857), higher %LLMP was associated with a significantly increased risk for future AEs (adjusted rate ratio (aRR) [95%CI]= 1.11[1.05-1.17]; Figure 1). Subgroup analyses by lung function category supported a significant association between increased %LLMP and future AEs in GOLD0 (aRR 1.45 [1.25-1.69]), but not in the COPD or PRISm subgroups (Figure 1). Conclusions A higher proportion of lower lobe mucus plugs is significantly associated with increased risk for future AEs among tobacco-exposed persons. Despite having the lowest burden of MPs, the highest risk for prospective AEs with increasing %LLMP was observed in the subgroup with normal spirometry (GOLD0).
Impact of Global Lung Initiative (GLI) Based Pulmonary Function Reclassification on Post Hematopoietic Stem Cell Transplant Outcomes: A Retrospective Analysis of 3,120 Patients
Soto, Felipe, Suresh, A. , Rondón, Gabriela , Yadav, Hemang , Sheshadri, Ajay

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2926-A2926

10.1164/ajrccm.2025.211.abstracts.a2926 Get It

Abstract Rationale: Hematopoietic cell transplantation (HCT) risk scores have seen minimal updates over the past 20 years, despite advancements in clinical practice. Pulmonary function test (PFT) thresholds, initially based on NHANES reference equations, now have alternative reference standards from the Global Lung Function Initiative (GLI) 2012 and GLI-Global, which may reclassify patients and affect outcomes. This study investigates the impact of GLI reclassification on outcomes in HCT, comparing traditional fixed thresholds with continuous (z-score) risk assessment models. Methods: A retrospective review of 3,120 adult patients who underwent autologous HCT at MD Anderson Cancer Center from 1999 to 2015 was conducted. Primary endpoints were ICU admission, mechanical ventilation (IMV), and survival within 120 days post-transplant. PFT measures (FEV1, FVC, DLCO) were calculated using GLI-2012 and GLI-Global reference equations, analyzed both continuously (z-scores) and categorically by ATS/ERS guidelines. Cox proportional hazards and logistic regression models were employed, with AUROC comparisons to evaluate predictive performance. Results: The cohort had a mean age of 49 years (SD 14), with 41% female and 77% White. Of the 3,120 patients included in the study, the cohort consisted of 77% White, 5.4% Black, 3.3% Asian, and 14% identifying as other ethnicities. At 120 days, mortality was 1% (n=41), ICU admission 5% (n=169), and IMV 2% (n=70). Continuous DLCO was associated with a lower risk of mortality (HR: 0.75; p=0.03), ICU admission (OR: 0.83; p=0.01), and IMV (OR: 0.80; p=0.02). GLI-Global's FEV1 z-scores were also significant for mortality (HR: 0.70; p=0.01), ICU admission (OR: 0.74; p<0.0001), and IMV (OR: 0.70; p=0.0003). Categorical analyses showed significant mortality reduction with normal DLCO (HR: 0.46; p=0.01) and ICU admission reduction with normal FEV1 GLI-2012 (OR: 0.63; p=0.02). Reclassification by race, as shown in Figure 1, indicated that race-specific equations overestimated PFT values in Black patients and underestimated them in Asian patients. Conclusion: Reclassification by GLI reference equations, particularly using continuous z-scores, significantly influences post-HCT outcomes, suggesting that continuous assessment may improve risk stratification. Including race does not improve the model's performance. These findings support integrating updated PFT references and continuous risk models into HCT prognostic tools for enhanced clinical decision-making.
Impacts of Psychological Well-being and Physical Activity on Health-related Quality of Life in Patients With Fibrotic Interstitial Lung Disease
Peterson, U.D., Hoult, Johanna, Moua, T., Roy, M.J.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2921-A2921

10.1164/ajrccm.2025.211.abstracts.a2921 Get It

Abstract Rationale: Patients with fibrotic interstitial lung (f-ILD) disease often have decreased physical activity (PA) due to high symptom burden, with shortness of breath, cough, anxiety, and fatigue affecting health-related quality of life (HR-QOL). Previously undiagnosed anxiety and depression has been described in f-ILD though contributing factors remain unknown. We hypothesize that significant rates of disease-related anxiety and depression may be detected but not persist, representing situational or short-term responses to disease burden. We also hypothesize that real-world PA is an important contributor to or reflection of HR-QOL and associated with selected patient-reported outcome measures (PROMs). Methods: This was a single-center prospective observational cohort enrolling adult patients with established f-ILD. PROM questionnaires were sent electronically to patients at study enrollment and 3 months. These included the Modified Medical Research Council (mMRC), Fatigue Severity Scale (FSS), Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), Self-Management Ability Scale-30 (SMAS-30), and abbreviated Prolife of Mood States (POMS). PA was defined as mean number of steps per day over a 7-day period as measured by at-home Actigraphy, obtained at enrollment and 3 months (within 2 weeks of completing PROM questionnaires). Results: Forty five patients were included (mean age 69, female 49 %, non-IPF f-ILD 78%, mean forced vital capacity 77%). Baseline GAD-7 anxiety scores were ‘moderate’ in 45% and ‘severe’ in 5%. PHQ-9 depression scores were ‘moderately severe’ in 30% and ‘severe’ in 5%. Mean GAD-7 and PHQ scores were no different at baseline and three months (GAD7 10.18 vs 10, P = 0.653; PHQ-9 12.82 vs 13.32, P = 0.294). mMRC, FSS, and SMAS-30 scores were associated with daily step activity. A one-point increase in mMRC or FSS (greater dyspnea or fatigue) was associated with a decrease in daily steps of 1400 [CI: (-2000, -600), ] or 90 steps [CI: (-160, -15))], respectively. A one-point increase in SMAS-30 (greater self-management) was associated with an increase of 108 steps per day [CI: (25, 190-0.38) ]. Anxiety, depression, and mood did not appear to be associated with step activity GAD-7-4.5 (P = 0.982), PHQ-9-211.5 (P = 0.13), POMS -36.5 (P = 0.096). Conclusions: Clinical symptoms of anxiety and depression are prevalent in patients with f-ILD and do not appear diminished or improved in the short term. Dyspnea, fatigue, and self-management ability are associated with real-world measures of physical activity.
Pulmonary Embolism Mortality Trends and Disparities in Patients With Cancer in the United States, 1999 – 2020
Marco, Teresa Navío, Hoffer, Mariëtte J.V. , Ritter, Julia, Sumner, Richard E., Ibrahim, Radwa, Ritter, John , Soin, S., Pham, H.N., Marco, T., Hoffer, M., Sumner, R., Ibrahim, R.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2842-A2842

10.1164/ajrccm.2025.211.abstracts.a2842 Get It

Abstract RATIONALE: The diagnosis of Pulmonary Embolism (PE) is associated with high mortality and morbidity. In patients with cancer, high-risk pulmonary emboli further escalate these risks. Ensuring access to the necessary resources for appropriate intervention is crucial for improving patient outcomes. However, the resource-intensive nature of managing multiple life-threatening conditions can create barriers for certain demographic populations, leading to disparities in outcomes. To address this issue, we explored mortality trends among diverse groups based on gender, ethnicity, and geographical background in the United States from 1999-2000. METHODS: We obtained mortality data from death certificate queries in the Centers for Disease Control and Prevention Wide-range Online Data for Epidemiologic Research database. Queries included all decedents with the underlying cause of death being PE (I26) in patients with a diagnosis of cancer (C00 – C97). Age-adjusted mortality rates (AAMR) per 100,000 people were compared across demographic populations, and 95% Confidence Intervals were standardized to the year 2000. Log-linear regression models were utilized to assess temporal mortality shifts and calculate annual percentage change (APC) from 1999 to 2020. RESULTS: A total of 179483 PE-related deaths was reported in patients with cancer. The AAMR increased from 2.14 [2.08-2.19] in 1999 to 3.05 [3.00-3.11] in 2020. The cumulative AAMR was 2.42 [2.41-2.43] with an average APC of +1.56% (p<0.001). The mortality rate accelerated following the year 2016, with the years prior having an APC of +0.69%, (p<0.001) and the years following having an APC +5.33% (p<0.001). A higher mortality was observed in males (AAMR 2.71 [2.69-2.73]) than females (2.20 [2.18-2.21]), in rural communities (AAMR 2.50 [2.47-2.53]) compared to urban communities (AAMR 2.38 [2.37-2.40]), and in non-Hispanic (AAMR 2.48 [2.47-2.49]) populations over Hispanic populations (AAMR 1.45 [1.42-1.48]). Mortality was highest in the Black population (AAMR 3.65 [3.60-3.69]), followed by White population (AAMR 2.33 [2.32-2.34]), American Natives (AAMR 1.43 [1.33-1.54]), and Asian (AAMR 1.04 [1.00-1.08]). Geographically, Midwest (AAMR 2.58 [2.56-2.61]) had the highest mortality while the South (AAMR 2.26 [2.24-2.28]) had the lowest mortality. CONCLUSIONS: We identified significant disparities in mortality related to pulmonary embolism (PE) among cancer patients across different demographic populations. Further investigation into these healthcare inequities is essential for addressing the disparities affecting various groups.
Pulmonary Sclerosing Pneumocytoma: An Uncommon Mimic of Malignancy
Wadle, Ronald W., Egan, A.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2803-A2803

10.1164/ajrccm.2025.211.abstracts.a2803 Get It

Abstract Introduction: Pulmonary sclerosing pneumocytoma, formerly known as sclerosing hemangioma, is an uncommon benign neoplasm most recently classified by the World Health Organization as an adenoma. It occurs most commonly in middle-aged women of East Asian descent, in whom it is most often discovered incidentally on imaging. It typically appears as a single, well-circumscribed lesion on CT that lacks specific defining characteristics and can appear similar to malignancies such as pulmonary adenocarcinoma. Therefore, diagnosis relies on histopathology. The tumor is derived from respiratory epithelial cells expressing TTF-1 in both round and surface cells, and immunohistochemistry (IHC) staining is positive for both TTF-1 and EMA. Description of Case: A 52-year-old female from Southeast Asia presented to primary care clinic reporting atypical chest pain. She denied shortness of breath, cough, fever, night sweats, or weight loss. She had no prior smoking history, but there was a remote history of chewing tobacco. Chest x-ray revealed a retrocardiac left lower lobe pulmonary nodule. CT chest was obtained and revealed a solid left lower lobe pulmonary nodule measuring 2.2 cm in diameter. The nodule was mildly FDG avid on subsequent PET-CT with SUVmax 2.8, noted to be suspicious for a lesion on the pulmonary adenocarcinoma spectrum. She opted for surgical removal and underwent thoracoscopic left lower lobe wedge resection. Pathology demonstrated sclerosing pneumocytoma with IHC stains positive for TTF1, EMA, and keratin AE1/AE3. The follow-up CT chest showed no evidence of local recurrence or residual tumor. Discussion: Pulmonary sclerosing pneumocytoma is an uncommon benign neoplasm of the lung that can be easily mistaken for malignancy such as pulmonary adenocarcinoma given its imaging characteristics and FDG avidity on PET-CT. It must be considered in the differential for lung nodules, particularly in middle-aged women of East Asian descent. Diagnosis is made with biopsy showing both cuboidal surface cells and stromal round cells, with IHC staining positively for TTF-1 and EMA. However, these tumors remain difficult to diagnose in frozen section, small biopsies, and cytology, because they are easily mistaken for adenocarcinoma or carcinoid tumors. The clinical course is generally benign, but very rarely there is metastasis or recurrence.
Diagnosis of Sub-centimeter Nodules Through Shape-sensing Robotic Assisted Bronchoscopy: Real-world Outcomes from the Ion Registry
Pritchett, M., Garwood, Susan, Jiwani, Alisha, Abedi, Ali , Bawaadam, Hasnain , Icard, Bradley , Revelo, Alberto , Reisenauer, Janani , Oh, Saecheol , Postigo, M., Garwood, S., Peralta, A.R.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2720-A2720

10.1164/ajrccm.2025.211.abstracts.a2720 Get It

Abstract RATIONALE: As technology for biopsy of peripheral pulmonary nodules advances, the size of suspicious nodules referred for biopsy has decreased. This can be partly attributed to tools such as shape-sensing robotic-assisted bronchoscopy (ssRAB), which can increase the likelihood of a diagnostic result. Literature describing the biopsy of sub-centimeter nodules is primarily single center with a reported diagnostic yield for robotic bronchoscopy of 67%1, and 71%2 for CT-guided percutaneous biopsy; robust prospective multi-center data is needed to further understand the feasibility and clinical value of <1cm nodule biopsies. Herein, we report data from the prospective Ion Registry describing outcomes for patients with sub-centimeter nodules biopsied using ssRAB. METHODS: Patients with at least one (1) nodule <1cm that underwent ssRAB biopsy were identified from those enrolled in the Ion Registry. Subjects with multiple lesions were included if all nodules were <1cm in largest diameter. Nodule and procedure characteristics are reported with descriptive statistics; diagnostic yield was assessed using the ATS/ACCP recommended guidelines of index biopsy results only. Safety was assessed as the rate of pneumothorax requiring intervention and Nashville Grade ≥3 bleeding. RESULTS: Fifty-four (54) subjects and 57 sub-centimeter nodules were identified across 9 centers and 15 investigators; procedures were completed October 2023 through September 2024. The majority of nodules (47.4%) were incidental findings. Median nodule diameter was 8 mm (IQR: 7,9; range: 4.0-9.7 mm) with 66.7% of nodules located in the outer-third of the lung, and predominantly (57.9%) in the upper lobes. CT bronchus sign was present in 24.6% of nodules, and most (89.5%) nodule were solid. Median procedure time was 34.5 mins (IQR: 26,47; range: 9-89 mins); fixed or mobile CBCT was utilized for 80.7% (46/57) of nodules. The flexision biopsy needle and cryoprobe were used in 91% and 49% of biopsies, respectively. Diagnostic yield was 83% (45/54) using index biopsy results, 59% of which were malignant. No (0%) pneumothorax requiring intervention, Nashville Grade ≥3 bleeding events. CONCLUSION: Preliminary results from this prospective, multi-center registry cohort demonstrate peripheral nodules <1cm can be safely and effectively diagnosed through ssRAB biopsy and highlight the impact of ssRAB in enhancing lung nodule diagnosis, particularly when combined with CBCT. These findings suggest ssRAB may be considered a viable option for the biopsy of suspicious sub-centimeter nodules, further optimizing the management of patients with suspected lung cancer. REFERENCES:1. 10.1016/j.chest.2021.07.2169 2. https://doi.org/10.1016/j.clinimag.2020.04.040